We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our
Cookie Policy
.
Accept
Label
Search
SKIP TO CONTENT
SKIP NAVIGATION
Drug & Device Products
Books
FDAnews Books Library
Events
Form 483s Database
Publications
Webinar Training Pass
eCFR and Guidances
Clinical Products
Advertising
White Papers
Contact Us
About Us
COVID-19
Sign In
Create Account
Sign Out
My Account
Home
» Sandoz Launches Generic Cipralex in Europe
Sandoz Launches Generic Cipralex in Europe
June 17, 2014
Pharmaceuticals
Commercial Operations
Germany-based Sandoz has launched a version of Lundbeck’s antidepressant Cipralex in several European countries, the generic firm said.
To View This Article:
Login
Email
Password
Register
Remember Me
Forgot your password?
Subscribe To Generic Line
Buy This Article Now
Add this article to your cart for $40.00
Upcoming Events
18
Oct
MAGI's Clinical Research vConference — Fall 2021
28
Oct
Master Your Clinical Trial Budgets: A Step-by-Step Guide to Smarter Budgeting
03
Nov
Real-World Evidence in Medical Device Submissions
09
Nov
Maintaining Your Risk-Based Cleaning and Disinfectant Programs: Best Practices During COVID-19
11
Nov
The MDSAP Audit Process: Latest Developments and Best Practices
16
Nov
16th Annual FDA Inspections vSummit
Featured Products
Biological Risk Evaluation and Management for Medical Devices
GMP Inspection Preparation Checklist: A Tool for Internal Auditing
Featured Stories
Merck Touts Positive Study Results for HIV Pill
Excalibur COVID-19 Self-Testing System Gets CE Mark
Public Citizen Presses FDA to Make Panel Considering Makena Withdrawal Balanced
Thermo Fisher Scientific’s Saliva-Based COVID-19 Test Gets EUA
The Revised ICH E8:
A Guide to New Clinical Trial Requirements
Learn More
